Outcomes of the 340B Drug Pricing Program: A Scoping Review

IMPORTANCE: The 340B Drug Pricing Program requires manufacturers to offer discounted drug prices to support safety net hospitals and clinics (covered entities) providing care to low-income populations. Amid expansion, the program has received criticism and calls for reform. OBJECTIVE: To assess the...

Descripción completa

Detalles Bibliográficos
Autores principales: Knox, Ryan P., Wang, Junyi, Feldman, William B., Kesselheim, Aaron S., Sarpatwari, Ameet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665972/
https://www.ncbi.nlm.nih.gov/pubmed/37991784
http://dx.doi.org/10.1001/jamahealthforum.2023.3716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665972/
https://www.ncbi.nlm.nih.gov/pubmed/37991784
http://dx.doi.org/10.1001/jamahealthforum.2023.3716

Ejemplares similares